deng yue

Erstellt neuen Artikel

3 d - übersetzen

Luvometinib: Exploring New Frontiers in Targeted Therapy—From MET-Altered Lung Cancer to a Broad Multi-Tumor Strategy | #cancer #met

Luvometinib: Exploring New Frontiers in Targeted Therapy—From MET-Altered Lung Cancer to a Broad Multi-Tumor Strategy

Luvometinib: Exploring New Frontiers in Targeted Therapy—From MET-Altered Lung Cancer to a Broad Multi-Tumor Strategy

Lumosertib is an oral small molecule drug that belongs to the MET kinase inhibitor class. It is mainly used to treat patients with tumors carrying specific gene mutations, such as advanced or metastatic cancers in non-small cell lung cancer (NSCLC) driven by MET exon14 skipping mutations.

Gefällt mir

Kommentar

Teilen

hat ihr Profilbild geändert

3 d

Gefällt mir

Kommentar

Teilen

Mehr Beiträge laden

Info

2 Beiträge
Weiblich
12/20/03
Lebt in China

Alben

0

folgt

0

0

0

Gruppen

0